• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性胸腔积液的胸腔镜姑息治疗:273例患者的治疗结果

Thoracoscopic palliative treatment of malignant pleural effusions: results in 273 patients.

作者信息

Arapis K, Caliandro R, Stern J-B, Girard P, Debrosse D, Gossot D

机构信息

Thoracic Department, Institut Mutualiste Montsouris, 42 Bd Jourdan, F-75014, Paris, France.

出版信息

Surg Endosc. 2006 Jun;20(6):919-23. doi: 10.1007/s00464-005-0534-6. Epub 2006 May 2.

DOI:10.1007/s00464-005-0534-6
PMID:16738983
Abstract

BACKGROUND

The aim of this study was to analyze the results of pleurodesis for malignant pleural effusion performed by surgeons.

PATIENTS AND METHODS

A series of 273 patients with malignant pleural effusion underwent thoracoscopy with the aim of performing a palliative pleurodesis. There were 94 males (34.4%) and 175 females (64.1%), ranging in age from 15 to 94 years (mean age: 60.6 years). The effusion was on the right side in 136 patients (49.8%), on the left side in 110 (40.3%), and bilateral in 27 (9.9%). Thoracoscopy was performed under general anaesthesia in all patients. Pleural biopsy was performed in two thirds of the patients (70.7%). Pleurodesis was produced by instillation of 5g of sterile asbestos-free talc; the chest tube was left in place a minimum of 3 days. It was removed when fluid drainage was less than 200 ml/24 h. Patients were usually discharged the day after chest tube removal.

RESULTS

There was no intraoperative mortality. Two patients (0.7%) had intraoperative complications; 17 (6.2%) underwent a bilateral pleurodesis, and 10 (3.7%) had a pericardiopleural window. In 32 patients (11.7%) no pleurodesis was done, either because the lung did not properly re-expand (5.2%), or because of suspected infection, e.g., false membranes (1.9%), or because of multiple adhesions (4.6%). Finally, only 241 patients (88.3%) had a talc poudrage at the time of thoracoscopy. Duration of postoperative pleural drainage ranged between 1 and 11 days (mean: 3.64 days). The postoperative hospital stay ranged from 2 to 21 days (mean: 7.1 days). Pleural empyema occurred in 4 patients (1.5%) and was lethal in one patient. The mean follow-up period was 8.39 (7.2 months, and 172 patients had regular follow up. In this group, there were 24 recurrences (14%), 12 of which were treated by repeat pleurodesis. The results were very good in 133 patients (77.3%), acceptable in 35 patients (20.3%), and there was a failure in 4 patients (2.4%).

CONCLUSIONS

Results of surgical thoracoscopy for malignant pleural effusion are good, with low morbidity. However, in debilitated patients, bedside talc slurry may be preferable.

摘要

背景

本研究旨在分析外科医生进行恶性胸腔积液胸膜固定术的结果。

患者与方法

一系列273例恶性胸腔积液患者接受了胸腔镜检查,目的是进行姑息性胸膜固定术。其中男性94例(34.4%),女性175例(64.1%),年龄在15至94岁之间(平均年龄:60.6岁)。胸腔积液位于右侧136例(49.8%),左侧110例(40.3%),双侧27例(9.9%)。所有患者均在全身麻醉下进行胸腔镜检查。三分之二的患者(70.7%)进行了胸膜活检。通过注入5g无菌无石棉滑石粉进行胸膜固定术;胸管至少留置3天。当引流量少于200ml/24小时时拔除胸管。患者通常在拔除胸管后的次日出院。

结果

无术中死亡。2例患者(0.7%)出现术中并发症;17例(6.2%)进行了双侧胸膜固定术,10例(3.7%)有胸膜心包开窗术。32例患者(11.7%)未进行胸膜固定术,原因要么是肺未完全复张(5.2%),要么是怀疑感染,如假膜形成(1.9%),要么是存在多处粘连(4.6%)。最后,仅241例患者(88.3%)在胸腔镜检查时进行了滑石粉喷洒。术后胸腔引流持续时间为1至ll天(平均:3.64天)。术后住院时间为2至21天(平均:7.1天)。4例患者(1.5%)发生了胸腔积脓,其中1例死亡。平均随访期为8.39个月(7.2个月至172个月),172例患者接受了定期随访。在该组中,有24例复发(14%),其中12例通过重复胸膜固定术进行了治疗。133例患者(77.3%)结果非常好,35例患者(20.3%)结果尚可,4例患者(2.4%)治疗失败。

结论

恶性胸腔积液的外科胸腔镜检查结果良好,发病率低。然而,对于身体虚弱的患者,床边滑石粉悬液可能更可取。

相似文献

1
Thoracoscopic palliative treatment of malignant pleural effusions: results in 273 patients.恶性胸腔积液的胸腔镜姑息治疗:273例患者的治疗结果
Surg Endosc. 2006 Jun;20(6):919-23. doi: 10.1007/s00464-005-0534-6. Epub 2006 May 2.
2
Thoracoscopy and talc poudrage compared with intercostal drainage and talc slurry infusion to manage malignant pleural effusion: the TAPPS RCT.胸腔镜和滑石粉喷洒与肋间引流和滑石粉混悬液灌注治疗恶性胸腔积液的比较:TAPPS RCT。
Health Technol Assess. 2020 Jun;24(26):1-90. doi: 10.3310/hta24260.
3
Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study.滑石粉喷洒术与滑石粉浆治疗恶性胸腔积液的前瞻性对照研究。
Eur J Cardiothorac Surg. 2006 Dec;30(6):827-32. doi: 10.1016/j.ejcts.2006.10.002.
4
Long-term follow-up of video-assisted talc pleurodesis in malignant recurrent pleural effusions.电视辅助滑石粉胸膜固定术治疗恶性复发性胸腔积液的长期随访
Eur J Cardiothorac Surg. 2002 Feb;21(2):302-5; discussion 305-6. doi: 10.1016/s1010-7940(01)01130-7.
5
Effect of Thoracoscopic Talc Poudrage vs Talc Slurry via Chest Tube on Pleurodesis Failure Rate Among Patients With Malignant Pleural Effusions: A Randomized Clinical Trial.胸腔镜滑石粉喷洒与经胸管注入滑石粉悬液对恶性胸腔积液患者胸膜固定术失败率的影响:一项随机临床试验
JAMA. 2020 Jan 7;323(1):60-69. doi: 10.1001/jama.2019.19997.
6
Clinical efficacy and safety of thoracoscopic talc pleurodesis in malignant pleural effusions.胸腔镜滑石粉胸膜固定术治疗恶性胸腔积液的临床疗效与安全性
Chest. 2005 Sep;128(3):1431-5. doi: 10.1378/chest.128.3.1431.
7
Effective treatment of malignant pleural effusion by minimal invasive thoracic surgery: thoracoscopic talc pleurodesis and pleuroperitoneal shunts in 101 patients.微创胸外科手术有效治疗恶性胸腔积液:101例患者的胸腔镜滑石粉胸膜固定术和胸膜腹膜分流术
Ann Thorac Surg. 2001 Jun;71(6):1809-12. doi: 10.1016/s0003-4975(01)02586-3.
8
A propensity-matched comparison of pleurodesis or tunneled pleural catheter in patients undergoing diagnostic thoracoscopy for malignancy.诊断性胸腔镜检查恶性肿瘤患者行胸膜固定术或隧道式胸腔引流管的倾向性匹配比较。
Ann Thorac Surg. 2013 Jul;96(1):259-63: discussion 263-4. doi: 10.1016/j.athoracsur.2013.03.063. Epub 2013 May 11.
9
Impact of pleural effusion pH on the efficacy of thoracoscopic mechanical pleurodesis in patients with breast carcinoma.胸腔积液pH值对乳腺癌患者胸腔镜机械性胸膜固定术疗效的影响
Eur J Cardiothorac Surg. 2004 Aug;26(2):432-6. doi: 10.1016/j.ejcts.2004.03.010.
10
Talc pleurodesis as surgical palliation of patients with malignant pleural effusion. Analysis of factors affecting survival.滑石粉胸膜固定术作为恶性胸腔积液患者的姑息性手术。影响生存的因素分析。
Anticancer Res. 2012 Nov;32(11):5071-4.

引用本文的文献

1
Malignant pleural disease.恶性胸膜疾病
Breathe (Sheff). 2023 Dec;19(4):230145. doi: 10.1183/20734735.0145-2023. Epub 2024 Feb 13.
2
Australasian Malignant PLeural Effusion (AMPLE)-3 trial: study protocol for a multi-centre randomised study comparing indwelling pleural catheter (±talc pleurodesis) versus video-assisted thoracoscopic surgery for management of malignant pleural effusion.澳大利亚恶性胸腔积液(AMPLE)-3 试验:一项多中心随机研究的研究方案,比较留置胸腔导管(±滑石粉胸膜固定术)与电视辅助胸腔镜手术治疗恶性胸腔积液。
Trials. 2022 Jun 27;23(1):530. doi: 10.1186/s13063-022-06405-7.
3
Complications of thoracoscopic talc insufflation for the treatment of malignant pleural effusions: a meta-analysis.

本文引用的文献

1
Pleurodesis in patients with malignant pleural effusions: talc slurry or bleomycin? Results of a prospective randomized trial.恶性胸腔积液患者的胸膜固定术:滑石粉悬液还是博来霉素?一项前瞻性随机试验的结果
World J Surg. 2004 Aug;28(8):749-53; discussion 753-4. doi: 10.1007/s00268-004-7269-8. Epub 2004 Aug 3.
2
Minimally invasive thoracic surgery for diagnostic assessment and palliative treatment in recurrent neoplastic pleural effusion.微创胸外科手术用于复发性肿瘤性胸腔积液的诊断评估和姑息治疗。
Thorac Cardiovasc Surg. 2004 Aug;52(4):191-5. doi: 10.1055/s-2004-820869.
3
Efficacy and safety of single-trocar technique for minimally invasive surgery of the chest in the treatment of noncomplex pleural disease.
胸腔镜滑石粉注射治疗恶性胸腔积液的并发症:荟萃分析。
J Cardiothorac Surg. 2021 May 4;16(1):125. doi: 10.1186/s13019-021-01475-1.
4
Multimodal approach to the management of malignant pleural effusions: role of thoracoscopy with pleurodesis and tunneled indwelling pleural catheters.恶性胸腔积液的多模式管理方法:胸腔镜联合胸膜固定术及隧道式留置胸腔导管的作用
J Thorac Dis. 2020 May;12(5):2803-2811. doi: 10.21037/jtd.2020.03.57.
5
Management of malignant pleural effusion: challenges and solutions.恶性胸腔积液的管理:挑战与解决方案
Cancer Manag Res. 2017 Jun 23;9:229-241. doi: 10.2147/CMAR.S95663. eCollection 2017.
6
Pleural controversies: indwelling pleural catheter vs. pleurodesis for malignant pleural effusions.胸膜疾病的争议:用于恶性胸腔积液的留置胸膜导管与胸膜固定术
J Thorac Dis. 2015 Jun;7(6):1052-7. doi: 10.3978/j.issn.2072-1439.2015.01.51.
7
Interventional pulmonologist perspective: treatment of malignant pleural effusion.介入肺科医生视角:恶性胸腔积液的治疗
Curr Treat Options Oncol. 2014 Dec;15(4):625-43. doi: 10.1007/s11864-014-0312-6.
8
Treatment of malignant pleural effusion: a cost-effectiveness analysis.恶性胸腔积液的治疗:成本效益分析。
Ann Thorac Surg. 2012 Aug;94(2):374-9; discussion 379-80. doi: 10.1016/j.athoracsur.2012.02.100. Epub 2012 May 10.
9
Mesothelioma: a review.间皮瘤:综述
Ochsner J. 2012 Spring;12(1):70-9.
10
Simple technique of talc delivery for video-assisted talc pleurodesis.
Gen Thorac Cardiovasc Surg. 2009 Feb;57(2):116-7. doi: 10.1007/s11748-008-0311-2. Epub 2009 Feb 12.
单孔技术用于胸部微创手术治疗非复杂性胸膜疾病的疗效及安全性
J Thorac Cardiovasc Surg. 2003 Nov;126(5):1618-23. doi: 10.1016/s0022-5223(03)00592-0.
4
Pleurodesis practice for malignant pleural effusions in five English-speaking countries: survey of pulmonologists.五个英语国家恶性胸腔积液的胸膜固定术实践:肺科医生调查
Chest. 2003 Dec;124(6):2229-38. doi: 10.1378/chest.124.6.2229.
5
BTS guidelines for the management of malignant pleural effusions.英国胸科学会恶性胸腔积液管理指南
Thorax. 2003 May;58 Suppl 2(Suppl 2):ii29-38. doi: 10.1136/thorax.58.suppl_2.ii29.
6
Lung damage in experimental pleurodesis induced by silver nitrate or talc: 1-year follow-up.
Chest. 2002 Dec;122(6):2122-6. doi: 10.1378/chest.122.6.2122.
7
Primary treatment of malignant pleural effusions: video-assisted thoracoscopic surgery poudrage versus tube thoracostomy.恶性胸腔积液的初始治疗:电视辅助胸腔镜滑石粉喷洒术与胸腔闭式引流术的对比
Am Surg. 2002 Nov;68(11):955-9; discussion 959-60.
8
Early and late mortality after pleurodesis for malignant pleural effusion.恶性胸腔积液行胸膜固定术后的早期和晚期死亡率
Ann Thorac Surg. 2002 Jul;74(1):213-7. doi: 10.1016/s0003-4975(02)03599-3.
9
Long-term follow-up of video-assisted talc pleurodesis in malignant recurrent pleural effusions.电视辅助滑石粉胸膜固定术治疗恶性复发性胸腔积液的长期随访
Eur J Cardiothorac Surg. 2002 Feb;21(2):302-5; discussion 305-6. doi: 10.1016/s1010-7940(01)01130-7.
10
Serious complications with talc slurry pleurodesis.滑石粉悬液胸膜固定术的严重并发症。
Respirology. 2001 Sep;6(3):181-5. doi: 10.1046/j.1440-1843.2001.00327.x.